Delivery Order SPE2DB24D1021-SPE2DB25FEYWF
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,788.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUCRISA 2% ointment, a prescription medication, with a period of performance through August 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the procurement of a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EUCRISA 2% ointment 60GM. The contract has a ceiling value of $2,101.23 and a period of performance ending on July 9, 2025. AmerisourceBergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,545.62 to supply Eucrisa 2% Ointment in 100-gram quantities. This non-competitive, competitively awarded delivery order represents a firm fixed price contract with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order issued under a larger Indefinite Delivery Contract vehicle. This...
- The Defense Logistics Agency awarded a $11,317.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Eucrisa 2% Ointment in 60-gram units. The contract is non-competitive and carries an ultimate completion date of September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,808.20 firm-fixed-price contract is for the supply of EUCRISA 2% ointment, a pharmaceutical product, with an ultimate completion date of August 17, 2023. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. The company is a major supplier of pharmaceutical products and medical supplies to...
- This contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $4,474.68, is for the supply of EUCRISA 2% ointment to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor and this award is a task order under their existing indefinite delivery contract (IDC) with DLA, which has a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $770 to Amerisourcebergen Drug Corporation to supply 60 grams of EUCRISA 2% ointment. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania by August 15, 2023 in fulfillment of this order issued under an existing DLA contract vehicle. No set-aside designation or subcontracting details were provided. The DLA manages the global supply chain for...
- This federal contract award, with an ID of SPE2DX15D7056|SPE2DX24F1UDE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the delivery of EUCRISA 2% ointment in 60 gram tubes. The firm fixed price delivery order has a ceiling value of $1,341.26 and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is the prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EUCRISA 2% ointment, a specialty pharmaceutical product, with a ceiling value of $1,554.51 and an ultimate completion date of January 14, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
- This is a $3,768.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUCRISA 2% ointment, a dermatological product, to support military healthcare programs. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYWFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment in 60-gram units under a firm fixed-price contract with a ceiling value of $4,106.07. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience fulfilling competitive medical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/22/25 |